{"id":"cimetidine-iv","safety":{"commonSideEffects":[{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Diarrhea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Gynecomastia (with chronic use)"},{"rate":null,"effect":"Confusion (especially in elderly or renal impairment)"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Cimetidine competitively inhibits histamine H2 receptors on gastric parietal cells, thereby decreasing both basal and stimulated gastric acid production. This reduction in gastric acidity is used to treat and prevent peptic ulcer disease, gastroesophageal reflux disease (GERD), and other acid-related conditions. The IV formulation allows for rapid onset of action in acute clinical settings.","oneSentence":"Cimetidine is a histamine H2-receptor antagonist that reduces gastric acid secretion by blocking histamine-mediated stimulation of parietal cells.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:05:54.121Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Peptic ulcer disease"},{"name":"Gastroesophageal reflux disease (GERD)"},{"name":"Zollinger-Ellison syndrome"},{"name":"Acute upper gastrointestinal bleeding prophylaxis"}]},"trialDetails":[{"nctId":"NCT04862585","phase":"PHASE2, PHASE3","title":"Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2021-10-07","conditions":"Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8","enrollment":130},{"nctId":"NCT05673590","phase":"PHASE3","title":"Utidelone Versus Docetaxel in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer","status":"UNKNOWN","sponsor":"Beijing Biostar Pharmaceuticals Co., Ltd.","startDate":"2023-05-12","conditions":"Locally Advanced or Metastatic Non-Small Cell Lung Cancer","enrollment":612},{"nctId":"NCT05922358","phase":"PHASE2","title":"Phase II Study of Reuse of Oxaliplatin Hypersensitivity in Gastrointestinal Tumors","status":"NOT_YET_RECRUITING","sponsor":"Fujian Cancer Hospital","startDate":"2023-09-01","conditions":"Gastrointestinal Tumors","enrollment":500},{"nctId":"NCT05866510","phase":"PHASE2","title":"Utidelone and Anlotinib in Advanced Recurrent Metastatic Esophageal Cancer","status":"UNKNOWN","sponsor":"Peking University","startDate":"2023-05-15","conditions":"Esophageal Cancer","enrollment":47},{"nctId":"NCT04280185","phase":"NA","title":"HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC)","status":"UNKNOWN","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-06-01","conditions":"Ovarian Cancer, Hyperthermic Intraperitoneal Chemotherapy","enrollment":202},{"nctId":"NCT01366378","phase":"PHASE1","title":"Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2007-01","conditions":"Healthy Adult Subjects","enrollment":18},{"nctId":"NCT00045799","phase":"PHASE3","title":"Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","startDate":"2002-05","conditions":"Upper Gastrointestinal Bleeding","enrollment":354},{"nctId":"NCT01411410","phase":"PHASE1","title":"Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer","status":"COMPLETED","sponsor":"Bayer","startDate":"2011-08-24","conditions":"Neoplasms","enrollment":55},{"nctId":"NCT01169012","phase":"PHASE1","title":"PK Study of Oral and IV Clofarabine in High Risk Myelodysplasia+Acute Leukemias","status":"COMPLETED","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2010-09","conditions":"Myelodysplastic Syndrome, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia","enrollment":13},{"nctId":"NCT02157376","phase":"PHASE3","title":"Stress Ulcer Prophylaxis of Intravenous Esomeprazole in Chinese Seriously Ill Patients","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2014-07","conditions":"Stress Ulcer Prophylaxis","enrollment":343},{"nctId":"NCT01953536","phase":"PHASE2","title":"Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)","status":"WITHDRAWN","sponsor":"Endocyte","startDate":"2014-04","conditions":"Breast Neoplasms","enrollment":""},{"nctId":"NCT00515073","phase":"PHASE2","title":"Papillary Serous Carcinoma of the Endometrium","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2001-04","conditions":"Endometrial Cancer","enrollment":30},{"nctId":"NCT01087021","phase":"PHASE1","title":"Effect of Cabazitaxel on the QTc Interval in Cancer Patients","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-03","conditions":"Neoplasms, Malignant","enrollment":45},{"nctId":"NCT00002733","phase":"PHASE2","title":"Biological Therapy in Treating Patients With Metastatic Cancer","status":"COMPLETED","sponsor":"Hoag Memorial Hospital Presbyterian","startDate":"1996-01","conditions":"Kidney Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific","enrollment":30}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":230,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Cimetidine IV","genericName":"Cimetidine IV","companyName":"Bausch Health Americas, Inc.","companyId":"bausch-health-americas-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Cimetidine is a histamine H2-receptor antagonist that reduces gastric acid secretion by blocking histamine-mediated stimulation of parietal cells. Used for Peptic ulcer disease, Gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}